Use of Combined Measurements of Serum Infliximab and Anti-infliximab Antibodies in the Treatment of Patients With Crohns Disease Failing Infliximab Therapy

NCT00851565 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Crohn's Disease

Interventions

PROCEDURE: Measurement of serum infliximab and anti-infliximab antibodies
PROCEDURE: Treatment according to current standards without knowledge of serum infliximab and anti-infliximab Ab status

Sponsor

Copenhagen University Hospital at Herlev

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]